Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…blinded, randomised controlled trial of plasma-activated water (PAW) for the treatment of non-healing DFU. 20 participants will be …
…ine has a slightly lower likelihood of success than intravenous ketamine; however, offers a useful needle-free alternative. With a clear…
…veloped a widespread, pruritic grade 3/4 eczematous reaction to pembrolizumab, significantly impacting his quality of life. Following cessati…
…t of exercise and the growth hormone-releasing hormone analogue tesamorelin on physical function.Methods TRIUMPH is a two-site, double-blin…
…trexate use increased until 2020 and plateaued thereafter while tocilizumab prescriptions rose, reaching over 25% in 2022. Male sex and bas…
…or inhibitors (TNF-i) use (OR 0.502, 95% CI 0.312 to 0.808) and tocilizumab use (OR 0.493, 95% CI 0.304 to 0.799) were associated with sarc…
…-1 (anti-PD-1). In preclinical PDAC models, triple therapy with GSK2643943A, MRTX1133 and anti-PD-1 elicited a robust therapeutic response …
…tal lobe was statistically analysed.Result The concentration of HbO in the SLE group was significantly lower than that in the healt…
… his 60s with metastatic Merkel cell carcinoma was treated with avelumab. After 8 months, he achieved complete resolution of cutaneous l…
…tients with asthma, acting upstream in the inflammatory cascade.Tezepelumab, a monoclonal antibody that targets TSLP, has shown clinical ef…
…t known well. Patients will be randomised to either intravenous tenecteplase (0.25 mg/kg, maximum 25 mg) or standard care. EVT is allowed in…